⌘K

Home/Filings/4/0001209191-06-064604

4//SEC Filing

NOVEN PHARMACEUTICALS INC 4

Accession 0001209191-06-064604

CIK 0000815838operating

View on SEC.gov Company Profile

Filed

Dec 12, 7:00 PM ET

Accepted

Dec 13, 4:35 PM ET

Size

15.1 KB

Accession

0001209191-06-064604

Insider Transaction Report

Form 4

Period: 2006-12-11

NOVEN PHARMACEUTICALS INCNOVN

VP & Chief Financial Officer

Transactions

Exercise/Conversion
Common Stock ($.0001 par value)
2006-12-11$10.45/sh+12,000$125,400→ 12,000 total
Sale
Common Stock ($.0001 par value)
2006-12-11$25.45/sh−2,500$63,625→ 9,500 total
Exercise/Conversion
Stock Option (Right to Buy)
2006-12-11−12,000→ 24,000 total
Exercise: $10.45Exp: 2010-11-04→ Common Stock ($.0001 par value) (12,000 underlying)
Sale
Common Stock ($.0001 par value)
2006-12-11$25.45/sh−2,000$50,894→ 7,500 total

Footnotes (1)

[F1]20% exercisable after 11/5/2004; 20% exercisable after 11/5/2005; 20% exercisable after 11/5/2006; 20% exercisable after 11/5/2007; and 20% exercisable after 11/5/2008.

Documents

1 file

4
doc4.xmlPrimary
FORM 4 SUBMISSION

Issuer

NOVEN PHARMACEUTICALS INC

CIK 0000815838

Entity typeoperating

IncorporatedDE

Related Parties

1

filerCIK 0000815838

Filing Metadata

Form type: 4
Filed: Dec 12, 7:00 PM ET
Accepted: Dec 13, 4:35 PM ET
Size: 15.1 KB

View on SEC.gov